ONTOLOGY REPORT - ANNOTATIONS
| Term: | carmustine |
|
| Accession: | CHEBI:3423
|
browse the term
|
| Definition: | An urea that has formula C5H9Cl2N3O2. |
| Synonyms: | exact_synonym: | 1,3-bis(2-chloroethyl)-1-nitrosourea |
| | related_synonym: | Bicnu (TN); C5H9Cl2N3O2; ClCCNC(=O)N(CCCl)N=O; Gliadel; InChI=1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11); InChIKey=DLGOEMSEDOSKAD-UHFFFAOYSA-N; N,N'-Bis(2-chloroethyl)-N-nitrosourea |
| | xref_casrn: | 154-93-8 |
| | xref: | ChEMBL:110840 "ChEMBL COMPOUND"; ChemIDplus:154-93-8 "CAS Registry Number"; DrugBank:DB00262 "DrugBank"; KEGG DRUG:154-93-8 "CAS Registry Number"; KEGG DRUG:D00254 "KEGG DRUG" |
| | xref_mesh: | MESH:D002330 |
| | xref: | Wikipedia:Carmustine "Wikipedia" |
|
|
carmustine
|
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcc2 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 2 |
|
affects response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcg5 |
ATP-binding cassette, subfamily G (WHITE), member 5 |
|
affects response to substance |
ISO |
6 |
8,027,647 |
8,064,425 |
RGD:6480464 |
CTD |
| G |
Acer2 |
alkaline ceramidase 2 |
|
increases expression |
EXP |
5 |
106,185,779 |
106,237,588 |
RGD:6480464 |
CTD |
| G |
Acpp |
acid phosphatase, prostate |
|
decreases expression |
EXP |
8 |
109,354,381 |
109,400,296 |
RGD:6480464 |
CTD |
| G |
Actc1 |
actin, alpha, cardiac muscle 1 |
|
decreases expression |
ISO |
3 |
99,901,022 |
99,906,558 |
RGD:6480464 |
CTD |
| G |
Actg2 |
actin, gamma 2, smooth muscle, enteric |
|
decreases expression |
ISO |
4 |
117,732,482 |
117,747,006 |
RGD:6480464 |
CTD |
| G |
Actn1 |
actinin, alpha 1 |
|
decreases expression |
ISO |
6 |
103,188,593 |
103,282,873 |
RGD:6480464 |
CTD |
| G |
Adam15 |
ADAM metallopeptidase domain 15 |
|
decreases expression |
ISO |
2 |
181,527,175 |
181,537,640 |
RGD:6480464 |
CTD |
| G |
Adamts4 |
ADAM metallopeptidase with thrombospondin type 1 motif, 4 |
|
decreases expression |
ISO |
13 |
87,142,442 |
87,151,783 |
RGD:6480464 |
CTD |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Adra1b |
adrenoceptor alpha 1B |
|
decreases expression |
ISO |
10 |
28,889,092 |
28,946,889 |
RGD:6480464 |
CTD |
| G |
Agr3 |
anterior gradient 3 homolog (Xenopus laevis) |
|
affects response to substance |
ISO |
6 |
54,629,032 |
54,652,276 |
RGD:6480464 |
CTD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
decreases response to substance |
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:6480464 |
CTD |
| G |
Akr1b1 |
aldo-keto reductase family 1, member B1 (aldose reductase) |
|
affects response to substance |
ISO |
4 |
61,645,438 |
61,659,530 |
RGD:6480464 |
CTD |
| G |
Akr1c1 |
aldo-keto reductase family 1, member C1 |
|
affects response to substance |
ISO |
17 |
77,084,306 |
77,112,994 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
affects response to substance |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
decreases expression |
ISO |
1 |
82,686,233 |
82,726,544 |
RGD:6480464 |
CTD |
| G |
Alad |
aminolevulinate dehydratase |
|
decreases expression |
ISO |
5 |
79,505,645 |
79,515,983 |
RGD:6480464 |
CTD |
| G |
Alad |
aminolevulinate dehydratase |
|
multiple interactions |
ISO |
5 |
79,505,645 |
79,515,983 |
RGD:6480464 |
CTD |
| G |
Alas2 |
aminolevulinate, delta-, synthase 2 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Aldh1a3 |
aldehyde dehydrogenase 1 family, member A3 |
|
affects response to substance |
ISO |
1 |
120,847,746 |
120,881,883 |
RGD:6480464 |
CTD |
| G |
Alox12 |
arachidonate 12-lipoxygenase |
|
affects response to substance |
ISO |
10 |
57,080,603 |
57,092,874 |
RGD:6480464 |
CTD |
| G |
Alox12 |
arachidonate 12-lipoxygenase |
|
decreases expression |
EXP |
10 |
57,080,603 |
57,092,874 |
RGD:6480464 |
CTD |
| G |
Alox15b |
arachidonate 15-lipoxygenase, type B |
|
decreases expression |
ISO |
10 |
55,951,005 |
55,960,265 |
RGD:6480464 |
CTD |
| G |
Amh |
anti-Mullerian hormone |
|
decreases expression |
ISO |
7 |
10,417,325 |
10,419,673 |
RGD:6480464 |
CTD |
| G |
Ank2 |
ankyrin 2, neuronal |
|
affects response to substance |
ISO |
2 |
224,182,431 |
224,501,751 |
RGD:6480464 |
CTD |
| G |
Ankrd1 |
ankyrin repeat domain 1 |
|
affects response to substance |
ISO |
1 |
240,316,123 |
240,324,804 |
RGD:6480464 |
CTD |
| G |
Ap1s2 |
adaptor-related protein complex 1, sigma 2 subunit |
|
affects response to substance |
ISO |
X |
51,329,574 |
51,356,406 |
RGD:6480464 |
CTD |
| G |
Apc |
adenomatous polyposis coli |
|
affects response to substance |
ISO |
18 |
26,732,147 |
26,790,383 |
RGD:6480464 |
CTD |
| G |
Apc2 |
adenomatosis polyposis coli 2 |
|
decreases expression |
ISO |
7 |
10,903,675 |
10,920,010 |
RGD:6480464 |
CTD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
increases response to substance |
ISO |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
decreases response to substance |
ISO |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
increases response to substance |
ISO |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
decreases response to substance |
ISO |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Aplnr |
apelin receptor |
|
decreases expression |
ISO |
3 |
68,365,637 |
68,369,282 |
RGD:6480464 |
CTD |
| G |
Aqp8 |
aquaporin 8 |
|
decreases expression |
ISO |
1 |
182,331,494 |
182,337,291 |
RGD:6480464 |
CTD |
| G |
Arf1 |
ADP-ribosylation factor 1 |
|
affects response to substance |
ISO |
10 |
45,516,609 |
45,532,091 |
RGD:6480464 |
CTD |
| G |
Arntl |
aryl hydrocarbon receptor nuclear translocator-like |
|
decreases expression |
EXP |
1 |
171,062,181 |
171,162,426 |
RGD:6480464 |
CTD |
| G |
Arpc2 |
actin related protein 2/3 complex, subunit 2 |
|
decreases expression |
ISO |
9 |
73,563,617 |
73,594,263 |
RGD:6480464 |
CTD |
| G |
Arrdc2 |
arrestin domain containing 2 |
|
affects response to substance |
ISO |
16 |
19,108,344 |
19,112,480 |
RGD:6480464 |
CTD |
| G |
Artn |
artemin |
|
decreases expression |
ISO |
5 |
138,390,981 |
138,394,250 |
RGD:6480464 |
CTD |
| G |
Atp1a3 |
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
|
decreases expression |
ISO |
1 |
80,280,714 |
80,309,834 |
RGD:6480464 |
CTD |
| G |
Atp4b |
ATPase, H+/K+ exchanging, beta polypeptide |
|
decreases expression |
ISO |
16 |
81,000,154 |
81,009,067 |
RGD:6480464 |
CTD |
| G |
Atp5d |
ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit |
|
decreases expression |
ISO |
7 |
11,072,820 |
11,075,906 |
RGD:6480464 |
CTD |
| G |
Atp6v0c |
ATPase, H+ transporting, lysosomal V0 subunit C |
|
decreases expression |
ISO |
10 |
13,415,671 |
13,420,715 |
RGD:6480464 |
CTD |
| G |
Atr |
ataxia telangiectasia and Rad3 related |
|
multiple interactions |
ISO |
8 |
100,936,342 |
101,014,881 |
RGD:6480464 |
CTD |
| G |
Atxn2l |
ataxin 2-like |
|
decreases expression |
ISO |
1 |
185,637,263 |
185,647,581 |
RGD:6480464 |
CTD |
| G |
Avpr1a |
arginine vasopressin receptor 1A |
|
increases expression |
ISO |
7 |
62,225,537 |
62,229,461 |
RGD:6480464 |
CTD |
| G |
B4galt5 |
UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5 |
|
decreases expression |
ISO |
3 |
158,440,189 |
158,449,419 |
RGD:6480464 |
CTD |
| G |
Baiap2 |
BAI1-associated protein 2 |
|
decreases expression |
ISO |
10 |
109,351,201 |
109,413,703 |
RGD:6480464 |
CTD |
| G |
Baiap3 |
BAI1-associated protein 3 |
|
decreases expression |
ISO |
10 |
14,490,205 |
14,499,554 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcl10 |
B-cell CLL/lymphoma 10 |
|
increases expression |
ISO |
2 |
244,116,880 |
244,126,393 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
affects response to substance |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
affects response to substance |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
affects response to substance |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
EXP |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Becn1 |
beclin 1, autophagy related |
|
decreases expression |
ISO |
10 |
90,317,957 |
90,333,329 |
RGD:6480464 |
CTD |
| G |
Bicd1 |
bicaudal D homolog 1 (Drosophila) |
|
decreases expression |
ISO |
4 |
186,922,060 |
187,069,288 |
RGD:6480464 |
CTD |
| G |
Blk |
B lymphoid tyrosine kinase |
|
decreases expression |
ISO |
15 |
42,643,847 |
42,682,793 |
RGD:6480464 |
CTD |
| G |
Bmp5 |
bone morphogenetic protein 5 |
|
affects response to substance |
ISO |
8 |
80,593,053 |
80,717,015 |
RGD:6480464 |
CTD |
| G |
Bmp7 |
bone morphogenetic protein 7 |
|
decreases expression |
ISO |
3 |
163,723,429 |
163,799,567 |
RGD:6480464 |
CTD |
| G |
Brf1 |
BRF1 homolog, subunit of RNA polymerase III transcription initiation factor IIIB (S. cerevisiae) |
|
decreases expression |
ISO |
6 |
137,962,953 |
138,007,641 |
RGD:6480464 |
CTD |
| G |
Calb2 |
calbindin 2 |
|
decreases expression |
ISO |
19 |
40,023,072 |
40,051,150 |
RGD:6480464 |
CTD |
| G |
Car6 |
carbonic anhydrase 6 |
|
decreases expression |
ISO |
5 |
167,332,219 |
167,350,880 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases expression |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
decreases activity |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Cat |
catalase |
|
multiple interactions |
EXP |
3 |
88,654,077 |
88,686,212 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
affects activity |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
decreases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
affects response to substance |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
affects response to substance |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccne1 |
cyclin E1 |
|
increases expression |
EXP |
1 |
90,568,189 |
90,577,426 |
RGD:6480464 |
CTD |
| G |
Cd151 |
CD151 molecule (Raph blood group) |
|
decreases expression |
ISO |
1 |
201,653,960 |
201,657,967 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
affects response to substance |
ISO |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd68 |
Cd68 molecule |
|
decreases expression |
ISO |
10 |
56,481,701 |
56,483,580 |
RGD:6480464 |
CTD |
| G |
Cd79a |
Cd79a molecule, immunoglobulin-associated alpha |
|
decreases expression |
ISO |
1 |
80,189,446 |
80,205,354 |
RGD:6480464 |
CTD |
| G |
Cd80 |
Cd80 molecule |
|
increases expression |
ISO |
11 |
64,045,358 |
64,070,072 |
RGD:6480464 |
CTD |
| G |
Cdc25b |
cell division cycle 25B |
|
decreases expression |
EXP |
3 |
118,893,716 |
118,903,516 |
RGD:6480464 |
CTD |
| G |
Cdh13 |
cadherin 13 |
|
affects response to substance |
ISO |
19 |
48,507,173 |
49,575,123 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
affects response to substance |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Cdkn2a |
cyclin-dependent kinase inhibitor 2A |
|
increases response to substance |
ISO |
5 |
108,908,749 |
108,916,380 |
RGD:6480464 |
CTD |
| G |
Cdkn3 |
cyclin-dependent kinase inhibitor 3 |
|
decreases expression |
EXP |
15 |
22,617,409 |
22,624,922 |
RGD:6480464 |
CTD |
| G |
Cdx4 |
caudal type homeo box 4 |
|
decreases expression |
ISO |
X |
91,285,627 |
91,294,213 |
RGD:6480464 |
CTD |
| G |
Ceacam3 |
carcinoembryonic antigen-related cell adhesion molecule 3 |
|
decreases expression |
ISO |
1 |
77,529,236 |
77,541,770 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
decreases expression |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cgref1 |
cell growth regulator with EF hand domain 1 |
|
increases expression |
EXP |
6 |
25,414,812 |
25,426,818 |
RGD:6480464 |
CTD |
| G |
Chd2 |
chromodomain helicase DNA binding protein 2 |
|
affects response to substance |
ISO |
1 |
128,609,727 |
128,720,325 |
RGD:6480464 |
CTD |
| G |
Chek1 |
checkpoint kinase 1 |
|
multiple interactions |
ISO |
8 |
37,954,322 |
37,974,748 |
RGD:6480464 |
CTD |
| G |
Chrm4 |
cholinergic receptor, muscarinic 4 |
|
decreases expression |
ISO |
3 |
76,301,988 |
76,309,729 |
RGD:6480464 |
CTD |
| G |
Chrnb3 |
cholinergic receptor, nicotinic, beta 3 (neuronal) |
|
decreases expression |
ISO |
16 |
69,028,625 |
69,069,274 |
RGD:6480464 |
CTD |
| G |
Chrng |
cholinergic receptor, nicotinic, gamma (muscle) |
|
decreases expression |
ISO |
9 |
86,012,089 |
86,018,199 |
RGD:6480464 |
CTD |
| G |
Ckm |
creatine kinase, muscle |
|
decreases expression |
ISO |
1 |
78,762,202 |
78,772,681 |
RGD:6480464 |
CTD |
| G |
Clic1 |
chloride intracellular channel 1 |
|
multiple interactions |
ISO |
20 |
3,498,935 |
3,842,500 |
RGD:6480464 |
CTD |
| G |
Clic1 |
chloride intracellular channel 1 |
|
decreases response to substance |
ISO |
20 |
3,498,935 |
3,842,500 |
RGD:6480464 |
CTD |
| G |
Cntnap1 |
contactin associated protein 1 |
|
increases expression |
ISO |
10 |
90,185,756 |
90,210,837 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
affects response to substance |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col5a3 |
collagen, type V, alpha 3 |
|
decreases expression |
EXP |
8 |
19,789,061 |
19,834,241 |
RGD:6480464 |
CTD |
| G |
Col9a1 |
collagen, type IX, alpha 1 |
|
decreases expression |
ISO |
9 |
22,907,157 |
22,990,836 |
RGD:6480464 |
CTD |
| G |
Cox6a2 |
cytochrome c oxidase subunit VIa polypeptide 2 |
|
decreases expression |
ISO |
1 |
187,464,579 |
187,465,301 |
RGD:6480464 |
CTD |
| G |
Crabp1 |
cellular retinoic acid binding protein 1 |
|
decreases expression |
ISO |
8 |
58,317,337 |
58,325,375 |
RGD:6480464 |
CTD |
| G |
Crat |
carnitine O-acetyltransferase |
|
decreases expression |
ISO |
3 |
9,447,585 |
9,461,180 |
RGD:6480464 |
CTD |
| G |
Crybb1 |
crystallin, beta B1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
affects response to substance |
ISO |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Csgalnact1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
|
affects response to substance |
ISO |
16 |
22,852,516 |
22,947,139 |
RGD:6480464 |
CTD |
| G |
Csrp3 |
cysteine and glycine-rich protein 3 (cardiac LIM protein) |
|
affects response to substance |
ISO |
1 |
98,601,681 |
98,611,747 |
RGD:6480464 |
CTD |
| G |
Cst5 |
cystatin D |
|
decreases expression |
ISO |
3 |
138,967,434 |
138,972,106 |
RGD:6480464 |
CTD |
| G |
Ctf1 |
cardiotrophin 1 |
|
decreases expression |
ISO |
1 |
187,001,445 |
187,006,655 |
RGD:6480464 |
CTD |
| G |
Ctnnal1 |
catenin (cadherin associated protein), alpha-like 1 |
|
increases expression |
ISO |
5 |
74,716,087 |
74,771,424 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
increases expression |
EXP |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Cux2 |
cut-like homeobox 2 |
|
affects expression |
EXP |
12 |
35,850,093 |
35,910,414 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
affects response to substance |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
|
affects response to substance |
ISO |
14 |
18,677,129 |
18,679,175 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
|
multiple interactions |
ISO |
12 |
9,517,016 |
9,541,000 |
RGD:6480464 |
CTD |
| G |
Cyp3a9 |
cytochrome P450, family 3, subfamily a, polypeptide 9 |
|
multiple interactions |
ISO |
12 |
17,164,384 |
17,204,589 |
RGD:6480464 |
CTD |
| G |
Cyth1 |
cytohesin 1 |
|
increases expression |
ISO |
10 |
108,189,311 |
108,253,419 |
RGD:6480464 |
CTD |
| G |
Def6 |
differentially expressed in FDCP 6 homolog (mouse) |
|
affects response to substance |
ISO |
20 |
6,391,694 |
6,469,830 |
RGD:6480464 |
CTD |
| G |
Dhrs3 |
dehydrogenase/reductase (SDR family) member 3 |
|
affects response to substance |
ISO |
5 |
163,341,856 |
163,375,604 |
RGD:6480464 |
CTD |
| G |
Dhx16 |
DEAH (Asp-Glu-Ala-His) box polypeptide 16 |
|
decreases expression |
ISO |
20 |
3,009,770 |
3,022,969 |
RGD:6480464 |
CTD |
| G |
Dhx37 |
DEAH (Asp-Glu-Ala-His) box polypeptide 37 |
|
affects response to substance |
ISO |
12 |
32,288,945 |
32,309,505 |
RGD:6480464 |
CTD |
| G |
Dkk1 |
dickkopf 1 homolog (Xenopus laevis) |
|
increases response to substance |
ISO |
1 |
234,392,743 |
234,396,426 |
RGD:6480464 |
CTD |
| G |
Dmrtc2 |
DMRT-like family C2 |
|
affects response to substance |
ISO |
1 |
80,161,778 |
80,168,956 |
RGD:6480464 |
CTD |
| G |
Dna2 |
DNA replication helicase 2 homolog (yeast) |
|
affects response to substance |
ISO |
20 |
25,288,326 |
25,316,851 |
RGD:6480464 |
CTD |
| G |
Dnase1l2 |
deoxyribonuclease I-like 2 |
|
decreases expression |
ISO |
10 |
13,698,596 |
13,701,079 |
RGD:6480464 |
CTD |
| G |
Dvl1 |
dishevelled, dsh homolog 1 (Drosophila) |
|
decreases expression |
ISO |
5 |
172,705,951 |
172,717,626 |
RGD:6480464 |
CTD |
| G |
Dyrk1b |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1b |
|
affects response to substance |
ISO |
1 |
83,281,284 |
83,288,783 |
RGD:6480464 |
CTD |
| G |
E2f1 |
E2F transcription factor 1 |
|
increases expression |
ISO |
3 |
145,032,489 |
145,043,729 |
RGD:6480464 |
CTD |
| G |
Ednra |
endothelin receptor type A |
|
affects response to substance |
ISO |
19 |
32,042,366 |
32,108,153 |
RGD:6480464 |
CTD |
| G |
Eef1g |
eukaryotic translation elongation factor 1 gamma |
|
increases expression |
ISO |
1 |
211,640,954 |
211,651,560 |
RGD:6480464 |
CTD |
| G |
Eif2b1 |
eukaryotic translation initiation factor 2B, subunit 1 alpha |
|
increases expression |
ISO |
12 |
33,138,323 |
33,146,596 |
RGD:6480464 |
CTD |
| G |
Eif4a2 |
eukaryotic translation initiation factor 4A2 |
|
affects response to substance |
ISO |
11 |
79,950,592 |
79,957,185 |
RGD:6480464 |
CTD |
| G |
Eif6 |
eukaryotic translation initiation factor 6 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Elmo1 |
engulfment and cell motility 1 |
|
affects response to substance |
ISO |
17 |
51,989,458 |
52,552,704 |
RGD:6480464 |
CTD |
| G |
Enc1 |
ectodermal-neural cortex 1 |
|
increases expression |
EXP |
2 |
27,720,805 |
27,733,168 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
decreases expression |
ISO |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Espn |
espin |
|
increases expression |
EXP |
5 |
169,349,723 |
169,382,076 |
RGD:6480464 |
CTD |
| G |
Esrra |
estrogen related receptor, alpha |
|
increases expression |
ISO |
1 |
209,587,681 |
209,597,677 |
RGD:6480464 |
CTD |
| G |
Etv1 |
ets variant 1 |
|
affects response to substance |
ISO |
6 |
57,674,561 |
57,766,401 |
RGD:6480464 |
CTD |
| G |
Etv1 |
ets variant 1 |
|
affects expression |
EXP |
6 |
57,674,561 |
57,766,401 |
RGD:6480464 |
CTD |
| G |
Extl1 |
exostosin-like glycosyltransferase 1 |
|
affects response to substance |
ISO |
5 |
153,100,524 |
153,115,725 |
RGD:6480464 |
CTD |
| G |
Ezh2 |
enhancer of zeste homolog 2 (Drosophila) |
|
decreases expression |
ISO |
4 |
75,709,959 |
75,773,279 |
RGD:6480464 |
CTD |
| G |
F3 |
coagulation factor III (thromboplastin, tissue factor) |
|
increases expression |
EXP |
2 |
218,371,050 |
218,382,645 |
RGD:6480464 |
CTD |
| G |
Fancc |
Fanconi anemia, complementation group C |
|
affects response to substance |
ISO |
17 |
7,254,528 |
7,341,500 |
RGD:6480464 |
CTD |
| G |
Fancd2 |
Fanconi anemia, complementation group D2 |
|
increases ubiquitination |
ISO |
4 |
149,424,558 |
149,500,006 |
RGD:6480464 |
CTD |
| G |
Fancd2 |
Fanconi anemia, complementation group D2 |
|
affects localization |
ISO |
4 |
149,424,558 |
149,500,006 |
RGD:6480464 |
CTD |
| G |
Fbln5 |
fibulin 5 |
|
decreases expression |
EXP |
6 |
126,018,541 |
126,098,234 |
RGD:6480464 |
CTD |
| G |
Fbn1 |
fibrillin 1 |
|
decreases expression |
ISO |
3 |
112,608,480 |
112,804,118 |
RGD:6480464 |
CTD |
| G |
Fbxo32 |
F-box protein 32 |
|
affects response to substance |
ISO |
7 |
94,909,568 |
94,942,444 |
RGD:6480464 |
CTD |
| G |
Fech |
ferrochelatase |
|
multiple interactions |
ISO |
18 |
60,675,217 |
60,708,418 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
decreases response to substance |
ISO |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fhl2 |
four and a half LIM domains 2 |
|
affects response to substance |
ISO |
9 |
42,319,997 |
42,349,055 |
RGD:6480464 |
CTD |
| G |
Fkbp1a |
FK506 binding protein 1a |
|
decreases expression |
ISO |
3 |
141,861,237 |
141,880,797 |
RGD:6480464 |
CTD |
| G |
Fkbp5 |
FK506 binding protein 5 |
|
increases expression |
EXP |
20 |
6,637,478 |
6,686,768 |
RGD:6480464 |
CTD |
| G |
Fnta |
farnesyltransferase, CAAX box, alpha |
|
decreases expression |
ISO |
16 |
70,440,340 |
70,458,433 |
RGD:6480464 |
CTD |
| G |
Fnta |
farnesyltransferase, CAAX box, alpha |
|
increases expression |
ISO |
16 |
70,440,340 |
70,458,433 |
RGD:6480464 |
CTD |
| G |
Foxj1 |
forkhead box J1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
multiple interactions |
ISO |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
decreases expression |
ISO |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Fth1 |
ferritin, heavy polypeptide 1 |
|
decreases response to substance |
ISO |
1 |
212,430,453 |
212,432,741 |
RGD:6480464 |
CTD |
| G |
Ftl |
ferritin, light polypeptide |
|
decreases expression |
ISO |
1 |
95,929,248 |
95,931,092 |
RGD:6480464 |
CTD |
| G |
Fut8 |
fucosyltransferase 8 (alpha (1,6) fucosyltransferase) |
|
affects response to substance |
ISO |
6 |
99,871,195 |
100,010,833 |
RGD:6480464 |
CTD |
| G |
Fyn |
FYN oncogene related to SRC, FGR, YES |
|
decreases expression |
ISO |
20 |
43,501,853 |
43,695,567 |
RGD:6480464 |
CTD |
| G |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
|
decreases expression |
ISO |
14 |
39,568,677 |
39,705,897 |
RGD:6480464 |
CTD |
| G |
Gabra2 |
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
|
affects response to substance |
ISO |
14 |
39,568,677 |
39,705,897 |
RGD:6480464 |
CTD |
| G |
Gabra6 |
gamma-aminobutyric acid (GABA) A receptor, alpha 6 |
|
decreases expression |
ISO |
10 |
27,474,071 |
27,489,074 |
RGD:6480464 |
CTD |
| G |
Galnt15 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 15 |
|
affects response to substance |
ISO |
16 |
7,481,060 |
7,517,315 |
RGD:6480464 |
CTD |
| G |
Gamt |
guanidinoacetate N-methyltransferase |
|
decreases expression |
ISO |
7 |
10,959,990 |
10,962,720 |
RGD:6480464 |
CTD |
| G |
Garnl3 |
GTPase activating Rap/RanGAP domain-like 3 |
|
affects response to substance |
ISO |
3 |
11,976,369 |
12,076,318 |
RGD:6480464 |
CTD |
| G |
Gast |
gastrin |
|
decreases expression |
ISO |
10 |
89,273,628 |
89,276,192 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
EXP |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
EXP |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gcm1 |
glial cells missing homolog 1 (Drosophila) |
|
increases expression |
ISO |
8 |
83,018,975 |
83,032,211 |
RGD:6480464 |
CTD |
| G |
Gdi1 |
GDP dissociation inhibitor 1 |
|
increases expression |
ISO |
X |
160,299,115 |
160,305,777 |
RGD:6480464 |
CTD |
| G |
Gdi2 |
GDP dissociation inhibitor 2 |
|
increases expression |
ISO |
17 |
77,843,481 |
77,870,171 |
RGD:6480464 |
CTD |
| G |
Gdnf |
glial cell derived neurotrophic factor |
|
decreases response to substance |
ISO |
2 |
57,399,312 |
57,424,030 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
multiple interactions |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
decreases expression |
ISO |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Gfap |
glial fibrillary acidic protein |
|
decreases expression |
EXP |
10 |
92,059,881 |
92,068,555 |
RGD:6480464 |
CTD |
| G |
Ghsr |
growth hormone secretagogue receptor |
|
decreases expression |
ISO |
2 |
113,269,623 |
113,272,999 |
RGD:6480464 |
CTD |
| G |
Glrb |
glycine receptor, beta |
|
affects response to substance |
ISO |
2 |
172,451,807 |
172,522,841 |
RGD:6480464 |
CTD |
| G |
Gnrhr |
gonadotropin releasing hormone receptor |
|
increases expression |
ISO |
14 |
23,625,135 |
23,656,583 |
RGD:6480464 |
CTD |
| G |
Golga2 |
golgin A2 |
|
decreases expression |
ISO |
3 |
11,412,088 |
11,434,260 |
RGD:6480464 |
CTD |
| G |
Golga4 |
golgin A4 |
|
increases expression |
ISO |
8 |
123,404,540 |
123,504,104 |
RGD:6480464 |
CTD |
| G |
Gp1bb |
glycoprotein Ib (platelet), beta polypeptide |
|
decreases expression |
ISO |
11 |
84,369,795 |
84,370,972 |
RGD:6480464 |
CTD |
| G |
Gpr25 |
G protein-coupled receptor 25 |
|
decreases expression |
ISO |
13 |
49,299,541 |
49,300,620 |
RGD:6480464 |
CTD |
| G |
Gpr37 |
G protein-coupled receptor 37 |
|
decreases expression |
ISO |
4 |
52,166,918 |
52,188,983 |
RGD:6480464 |
CTD |
| G |
Gpr65 |
G-protein coupled receptor 65 |
|
increases expression |
ISO |
6 |
122,432,615 |
122,433,628 |
RGD:6480464 |
CTD |
| G |
Grb7 |
growth factor receptor bound protein 7 |
|
decreases expression |
ISO |
10 |
87,252,571 |
87,261,619 |
RGD:6480464 |
CTD |
| G |
Grn |
granulin |
|
decreases expression |
ISO |
10 |
91,536,135 |
91,542,239 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
decreases activity |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
affects response to substance |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
multiple interactions |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm1 |
glutathione S-transferase mu 1 |
|
decreases response to substance |
ISO |
2 |
203,575,444 |
203,580,821 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
decreases nitrosation |
ISO |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
affects metabolic processing |
ISO |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
multiple interactions |
ISO |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
decreases nitrosation |
ISO |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
multiple interactions |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstp1 |
glutathione S-transferase pi 1 |
|
decreases response to substance |
ISO |
1 |
206,627,398 |
206,629,866 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
decreases nitrosation |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects response to substance |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gstt1 |
glutathione S-transferase theta 1 |
|
affects metabolic processing |
ISO |
20 |
13,604,355 |
13,621,456 |
RGD:6480464 |
CTD |
| G |
Gtf2f1 |
general transcription factor IIF, polypeptide 1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Gucy1b2 |
guanylate cyclase 1, soluble, beta 2 |
|
decreases expression |
EXP |
15 |
41,620,373 |
41,668,802 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
decreases expression |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
affects localization |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
multiple interactions |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
increases phosphorylation |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
Hacl1 |
2-hydroxyacyl-CoA lyase 1 |
|
decreases expression |
EXP |
16 |
7,073,038 |
7,108,830 |
RGD:6480464 |
CTD |
| G |
Hadh |
hydroxyacyl-CoA dehydrogenase |
|
decreases expression |
ISO |
2 |
228,698,545 |
228,751,691 |
RGD:6480464 |
CTD |
| G |
Hagh |
hydroxyacyl glutathione hydrolase |
|
decreases expression |
ISO |
10 |
14,106,047 |
14,117,459 |
RGD:6480464 |
CTD |
| G |
Hcfc1 |
host cell factor C1 |
|
decreases expression |
ISO |
X |
159,875,671 |
159,900,536 |
RGD:6480464 |
CTD |
| G |
Hhat |
hedgehog acyltransferase |
|
affects response to substance |
ISO |
13 |
108,411,459 |
108,651,307 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
decreases response to substance |
EXP |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
EXP |
6 |
96,419,024 |
96,463,891 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnf1a |
HNF1 homeobox A |
|
decreases expression |
ISO |
12 |
42,919,574 |
42,945,670 |
RGD:6480464 |
CTD |
| G |
Hoxa4 |
homeo box A4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
increases mutagenesis |
ISO |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Icam5 |
intercellular adhesion molecule 5, telencephalin |
|
decreases expression |
ISO |
8 |
20,055,255 |
20,062,100 |
RGD:6480464 |
CTD |
| G |
Ids |
iduronate 2-sulfatase |
|
decreases expression |
ISO |
X |
156,641,266 |
156,661,031 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
decreases expression |
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
affects response to substance |
ISO |
1 |
238,609,171 |
238,611,236 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
decreases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
affects response to substance |
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
decreases expression |
EXP |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Ikbkg |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma |
|
decreases expression |
ISO |
X |
160,386,558 |
160,420,190 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
multiple interactions |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1r1 |
interleukin 1 receptor, type I |
|
affects response to substance |
ISO |
9 |
39,434,910 |
39,473,552 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
affects response to substance |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
multiple interactions |
EXP |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Inhba |
inhibin beta-A |
|
affects response to substance |
ISO |
17 |
57,244,466 |
57,257,531 |
RGD:6480464 |
CTD |
| G |
Inppl1 |
inositol polyphosphate phosphatase-like 1 |
|
decreases expression |
ISO |
1 |
159,278,131 |
159,292,740 |
RGD:6480464 |
CTD |
| G |
Insig1 |
insulin induced gene 1 |
|
decreases expression |
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:6480464 |
CTD |
| G |
Insl3 |
insulin-like 3 |
|
decreases expression |
ISO |
16 |
18,890,131 |
18,891,475 |
RGD:6480464 |
CTD |
| G |
Ipo4 |
importin 4 |
|
affects response to substance |
ISO |
15 |
33,761,275 |
33,771,195 |
RGD:6480464 |
CTD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
decreases expression |
ISO |
9 |
81,585,251 |
81,638,071 |
RGD:6480464 |
CTD |
| G |
Itga3 |
integrin, alpha 3 |
|
decreases expression |
ISO |
10 |
83,728,710 |
83,759,576 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
decreases expression |
ISO |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
increases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb3 |
integrin, beta 3 |
|
increases response to substance |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Itih1 |
inter-alpha trypsin inhibitor, heavy chain 1 |
|
decreases expression |
ISO |
16 |
6,364,102 |
6,378,251 |
RGD:6480464 |
CTD |
| G |
Kcna4 |
potassium voltage-gated channel, shaker-related subfamily, member 4 |
|
multiple interactions |
EXP |
3 |
92,781,795 |
92,784,921 |
RGD:6480464 |
CTD |
| G |
Kcnab2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
|
affects response to substance |
ISO |
5 |
169,624,099 |
169,710,725 |
RGD:6480464 |
CTD |
| G |
Kcnd2 |
potassium voltage-gated channel, Shal-related subfamily, member 2 |
|
multiple interactions |
EXP |
4 |
47,541,787 |
48,047,924 |
RGD:6480464 |
CTD |
| G |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
|
decreases expression |
ISO |
4 |
6,192,644 |
6,224,285 |
RGD:6480464 |
CTD |
| G |
Kif2c |
kinesin family member 2C |
|
decreases expression |
EXP |
5 |
137,473,698 |
137,498,974 |
RGD:6480464 |
CTD |
| G |
Kif5a |
kinesin family member 5A |
|
decreases expression |
ISO |
7 |
67,183,575 |
67,220,766 |
RGD:6480464 |
CTD |
| G |
Krt17 |
keratin 17 |
|
decreases expression |
ISO |
10 |
89,185,097 |
89,189,816 |
RGD:6480464 |
CTD |
| G |
Krt31 |
keratin 31 |
|
decreases expression |
ISO |
10 |
88,982,495 |
88,985,932 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
affects response to substance |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Lad1 |
ladinin 1 |
|
decreases expression |
ISO |
13 |
48,850,260 |
48,864,622 |
RGD:6480464 |
CTD |
| G |
Lair1 |
leukocyte-associated immunoglobulin-like receptor 1 |
|
increases expression |
ISO |
1 |
69,571,996 |
69,601,974 |
RGD:6480464 |
CTD |
| G |
Lamb3 |
laminin, beta 3 |
|
decreases expression |
ISO |
13 |
109,148,815 |
109,190,322 |
RGD:6480464 |
CTD |
| G |
Lbp |
lipopolysaccharide binding protein |
|
affects response to substance |
ISO |
3 |
149,016,605 |
149,043,530 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
increases response to substance |
ISO |
3 |
11,511,402 |
11,514,747 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
multiple interactions |
EXP |
3 |
11,511,402 |
11,514,747 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
increases response to substance |
EXP |
3 |
11,511,402 |
11,514,747 |
RGD:6480464 |
CTD |
| G |
Ldlr |
low density lipoprotein receptor |
|
affects uptake |
ISO |
8 |
20,824,040 |
20,846,920 |
RGD:6480464 |
CTD |
| G |
Leprel2 |
leprecan-like 2 |
|
affects response to substance |
ISO |
4 |
160,964,297 |
160,978,321 |
RGD:6480464 |
CTD |
| G |
Lif |
leukemia inhibitory factor |
|
increases response to substance |
ISO |
14 |
84,887,856 |
84,890,630 |
RGD:6480464 |
CTD |
| G |
Lig1 |
ligase I, DNA, ATP-dependent |
|
decreases expression |
EXP |
1 |
73,728,892 |
73,767,429 |
RGD:6480464 |
CTD |
| G |
Lins |
lines homolog (Drosophila) |
|
affects response to substance |
ISO |
1 |
121,162,852 |
121,169,099 |
RGD:6480464 |
CTD |
| G |
Lman1l |
lectin, mannose-binding, 1 like |
|
affects response to substance |
ISO |
8 |
61,361,481 |
61,375,270 |
RGD:6480464 |
CTD |
| G |
Lmtk2 |
lemur tyrosine kinase 2 |
|
affects response to substance |
ISO |
12 |
10,754,175 |
10,836,896 |
RGD:6480464 |
CTD |
| G |
Lmx1b |
LIM homeobox transcription factor 1 beta |
|
decreases expression |
ISO |
3 |
12,571,947 |
12,651,590 |
RGD:6480464 |
CTD |
| G |
LOC100360316 |
hypothetical protein LOC100360316 |
|
decreases expression |
ISO |
16 |
33,979,260 |
33,979,532 |
RGD:6480464 |
CTD |
| G |
LOC498662 |
similar to RIKEN cDNA 2610019F03 |
|
affects response to substance |
ISO |
16 |
80,461,695 |
80,489,957 |
RGD:6480464 |
CTD |
| G |
Loxl1 |
lysyl oxidase-like 1 |
|
decreases expression |
ISO |
8 |
62,083,052 |
62,106,827 |
RGD:6480464 |
CTD |
| G |
Lrch4 |
leucine-rich repeats and calponin homology (CH) domain containing 4 |
|
decreases expression |
ISO |
12 |
19,694,434 |
19,705,423 |
RGD:6480464 |
CTD |
| G |
Lrmp |
lymphoid-restricted membrane protein |
|
decreases expression |
ISO |
4 |
182,769,091 |
182,823,096 |
RGD:6480464 |
CTD |
| G |
Lsp1 |
lymphocyte-specific protein 1 |
|
decreases expression |
EXP |
1 |
202,707,305 |
202,741,026 |
RGD:6480464 |
CTD |
| G |
Mad1l1 |
MAD1 mitotic arrest deficient-like 1 (yeast) |
|
decreases expression |
ISO |
12 |
14,793,899 |
15,107,476 |
RGD:6480464 |
CTD |
| G |
Map4k2 |
mitogen activated protein kinase kinase kinase kinase 2 |
|
decreases expression |
ISO |
1 |
209,121,164 |
209,136,316 |
RGD:6480464 |
CTD |
| G |
Mapk10 |
mitogen activated protein kinase 10 |
|
decreases expression |
ISO |
14 |
7,719,595 |
8,010,694 |
RGD:6480464 |
CTD |
| G |
Masp1 |
mannan-binding lectin serine peptidase 1 |
|
affects response to substance |
ISO |
11 |
79,532,504 |
79,602,755 |
RGD:6480464 |
CTD |
| G |
Mat1a |
methionine adenosyltransferase I, alpha |
|
decreases expression |
ISO |
16 |
17,548,582 |
17,563,989 |
RGD:6480464 |
CTD |
| G |
Mdk |
midkine |
|
decreases expression |
ISO |
3 |
76,309,988 |
76,311,345 |
RGD:6480464 |
CTD |
| G |
Mdm4 |
Mdm4 p53 binding protein homolog (mouse) |
|
multiple interactions |
ISO |
13 |
45,895,832 |
45,931,421 |
RGD:6480464 |
CTD |
| G |
Mdm4 |
Mdm4 p53 binding protein homolog (mouse) |
|
decreases response to substance |
ISO |
13 |
45,895,832 |
45,931,421 |
RGD:6480464 |
CTD |
| G |
Med1 |
mediator complex subunit 1 |
|
decreases expression |
ISO |
10 |
86,917,525 |
86,959,080 |
RGD:6480464 |
CTD |
| G |
Mgat3 |
mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase |
|
decreases expression |
ISO |
7 |
118,429,750 |
118,457,125 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
affects response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases activity |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
affects response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases expression |
EXP |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
increases alkylation |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
affects response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
affects response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
affects response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
affects response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
affects response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
decreases response to substance |
ISO |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgst2 |
microsomal glutathione S-transferase 2 |
|
affects response to substance |
ISO |
2 |
140,546,939 |
140,568,616 |
RGD:6480464 |
CTD |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
affects response to substance |
ISO |
8 |
115,616,396 |
115,653,471 |
RGD:6480464 |
CTD |
| G |
Mlph |
melanophilin |
|
affects response to substance |
ISO |
9 |
90,113,308 |
90,149,114 |
RGD:6480464 |
CTD |
| G |
Mpg |
N-methylpurine-DNA glycosylase |
|
decreases response to substance |
ISO |
10 |
15,643,334 |
15,649,561 |
RGD:6480464 |
CTD |
| G |
Mpst |
mercaptopyruvate sulfurtransferase |
|
affects response to substance |
ISO |
7 |
116,359,466 |
116,364,146 |
RGD:6480464 |
CTD |
| G |
Msh2 |
mutS homolog 2 (E. coli) |
|
affects response to substance |
ISO |
6 |
11,199,906 |
11,258,350 |
RGD:6480464 |
CTD |
| G |
Msr1 |
macrophage scavenger receptor 1 |
|
decreases expression |
ISO |
16 |
56,278,223 |
56,345,472 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
affects response to substance |
ISO |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
multiple interactions |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
affects response to substance |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Muc2 |
mucin 2, oligomeric mucus/gel-forming |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mvd |
mevalonate (diphospho) decarboxylase |
|
decreases expression |
ISO |
19 |
52,722,306 |
52,732,312 |
RGD:6480464 |
CTD |
| G |
Mybl2 |
myeloblastosis oncogene-like 2 |
|
increases expression |
EXP |
3 |
153,925,908 |
153,954,323 |
RGD:6480464 |
CTD |
| G |
Mybph |
myosin binding protein H |
|
decreases expression |
ISO |
13 |
47,151,091 |
47,158,665 |
RGD:6480464 |
CTD |
| G |
Myd88 |
myeloid differentiation primary response 88 |
|
decreases expression |
ISO |
8 |
124,299,729 |
124,303,798 |
RGD:6480464 |
CTD |
| G |
Myod1 |
myogenic differentiation 1 |
|
decreases expression |
ISO |
1 |
96,910,190 |
96,912,900 |
RGD:6480464 |
CTD |
| G |
Myog |
myogenin |
|
decreases expression |
ISO |
13 |
47,243,712 |
47,246,301 |
RGD:6480464 |
CTD |
| G |
Nbl1 |
neuroblastoma 1, DAN family BMP antagonist |
|
affects response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ndufc1 |
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1 |
|
decreases expression |
ISO |
2 |
140,298,031 |
140,301,809 |
RGD:6480464 |
CTD |
| G |
Nek6 |
NIMA-related kinase 6 |
|
increases expression |
EXP |
3 |
18,348,698 |
18,381,895 |
RGD:6480464 |
CTD |
| G |
Nes |
nestin |
|
increases expression |
EXP |
2 |
180,051,907 |
180,060,947 |
RGD:6480464 |
CTD |
| G |
Nes |
nestin |
|
multiple interactions |
EXP |
2 |
180,051,907 |
180,060,947 |
RGD:6480464 |
CTD |
| G |
Nfat5 |
nuclear factor of activated T-cells 5, tonicity-responsive |
|
affects response to substance |
ISO |
19 |
37,154,326 |
37,242,191 |
RGD:6480464 |
CTD |
| G |
Nfe2l2 |
nuclear factor, erythroid derived 2, like 2 |
|
affects response to substance |
ISO |
3 |
58,366,693 |
58,394,116 |
RGD:6480464 |
CTD |
| G |
Nfib |
nuclear factor I/B |
|
affects response to substance |
ISO |
5 |
101,184,253 |
101,409,907 |
RGD:6480464 |
CTD |
| G |
Nfix |
nuclear factor I/X (CCAAT-binding transcription factor) |
|
affects response to substance |
ISO |
19 |
25,018,352 |
25,111,367 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases response to substance |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases response to substance |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Ngef |
neuronal guanine nucleotide exchange factor |
|
decreases expression |
EXP |
9 |
86,294,206 |
86,327,765 |
RGD:6480464 |
CTD |
| G |
Ngf |
nerve growth factor (beta polypeptide) |
|
affects activity |
EXP |
2 |
197,621,726 |
197,632,960 |
RGD:6480464 |
CTD |
| G |
Nid2 |
nidogen 2 (osteonidogen) |
|
decreases expression |
EXP |
15 |
4,801,183 |
4,856,895 |
RGD:6480464 |
CTD |
| G |
Nin |
ninein (GSK3B interacting protein) |
|
affects response to substance |
ISO |
6 |
92,135,196 |
92,229,044 |
RGD:6480464 |
CTD |
| G |
Nkd2 |
naked cuticle homolog 2 (Drosophila) |
|
affects response to substance |
ISO |
1 |
30,252,093 |
30,278,933 |
RGD:6480464 |
CTD |
| G |
Nkx2-2 |
NK2 homeobox 2 |
|
decreases expression |
ISO |
3 |
135,837,591 |
135,839,963 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases response to substance |
ISO |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
decreases response to substance |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Npas1 |
neuronal PAS domain protein 1 |
|
decreases expression |
ISO |
1 |
76,719,188 |
76,738,565 |
RGD:6480464 |
CTD |
| G |
Npas2 |
neuronal PAS domain protein 2 |
|
affects response to substance |
ISO |
9 |
38,255,362 |
38,434,352 |
RGD:6480464 |
CTD |
| G |
Npl |
N-acetylneuraminate pyruvate lyase |
|
affects response to substance |
ISO |
13 |
68,524,023 |
68,567,312 |
RGD:6480464 |
CTD |
| G |
Npr1 |
natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) |
|
decreases expression |
EXP |
2 |
182,724,916 |
182,740,242 |
RGD:6480464 |
CTD |
| G |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
|
affects response to substance |
ISO |
2 |
5,765,399 |
5,794,104 |
RGD:6480464 |
CTD |
| G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
|
affects expression |
EXP |
3 |
38,866,205 |
38,871,678 |
RGD:6480464 |
CTD |
| G |
Nrtn |
neurturin |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
decreases response to substance |
ISO |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Ogg1 |
8-oxoguanine DNA glycosylase |
|
decreases response to substance |
ISO |
4 |
149,209,745 |
149,219,081 |
RGD:6480464 |
CTD |
| G |
Omp |
olfactory marker protein |
|
decreases expression |
ISO |
1 |
155,388,635 |
155,389,185 |
RGD:6480464 |
CTD |
| G |
Orm1 |
orosomucoid 1 |
|
increases expression |
EXP |
5 |
80,325,042 |
80,328,194 |
RGD:6480464 |
CTD |
| G |
Pax8 |
paired box 8 |
|
decreases expression |
ISO |
3 |
2,671,478 |
2,726,801 |
RGD:6480464 |
CTD |
| G |
Pbx2 |
pre-B-cell leukemia homeobox 2 |
|
decreases expression |
ISO |
20 |
4,253,962 |
4,259,185 |
RGD:6480464 |
CTD |
| G |
Pcbd1 |
pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha |
|
decreases expression |
ISO |
20 |
28,448,703 |
28,454,184 |
RGD:6480464 |
CTD |
| G |
Pcdhb2 |
protocadherin beta 2 |
|
affects response to substance |
ISO |
18 |
30,104,780 |
30,107,179 |
RGD:6480464 |
CTD |
| G |
Pcdhgc3 |
protocadherin gamma subfamily C, 3 |
|
decreases expression |
ISO |
18 |
30,714,544 |
30,754,205 |
RGD:6480464 |
CTD |
| G |
Pcolce |
procollagen C-endopeptidase enhancer |
|
decreases expression |
ISO |
12 |
19,672,505 |
19,678,821 |
RGD:6480464 |
CTD |
| G |
Pcyt1a |
phosphate cytidylyltransferase 1, choline, alpha |
|
decreases expression |
ISO |
11 |
70,133,325 |
70,173,686 |
RGD:6480464 |
CTD |
| G |
Pde5a |
phosphodiesterase 5A, cGMP-specific |
|
affects response to substance |
ISO |
2 |
219,410,394 |
219,550,910 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
increases expression |
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pfkfb2 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
|
decreases expression |
ISO |
13 |
43,624,838 |
43,652,660 |
RGD:6480464 |
CTD |
| G |
Pfkm |
phosphofructokinase, muscle |
|
decreases expression |
ISO |
7 |
136,826,122 |
136,846,040 |
RGD:6480464 |
CTD |
| G |
Pfn1 |
profilin 1 |
|
decreases expression |
ISO |
10 |
57,531,661 |
57,534,366 |
RGD:6480464 |
CTD |
| G |
Pgm2 |
phosphoglucomutase 2 |
|
affects response to substance |
ISO |
14 |
46,827,166 |
46,862,298 |
RGD:6480464 |
CTD |
| G |
Phc2 |
polyhomeotic homolog 2 (Drosophila) |
|
affects response to substance |
ISO |
5 |
147,930,703 |
147,978,856 |
RGD:6480464 |
CTD |
| G |
Phlda1 |
pleckstrin homology-like domain, family A, member 1 |
|
affects response to substance |
ISO |
7 |
50,541,011 |
50,543,215 |
RGD:6480464 |
CTD |
| G |
Pik3c3 |
phosphatidylinositol 3-kinase, catalytic subunit type 3 |
|
affects response to substance |
ISO |
18 |
22,495,197 |
22,579,656 |
RGD:6480464 |
CTD |
| G |
Pik3cd |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta |
|
affects response to substance |
ISO |
5 |
166,735,274 |
166,761,189 |
RGD:6480464 |
CTD |
| G |
Pik3r3 |
phosphoinositide-3-kinase, regulatory subunit 3 (gamma) |
|
increases expression |
ISO |
5 |
136,497,494 |
136,566,473 |
RGD:6480464 |
CTD |
| G |
Pitpnc1 |
phosphatidylinositol transfer protein, cytoplasmic 1 |
|
affects response to substance |
ISO |
10 |
96,594,391 |
96,871,091 |
RGD:6480464 |
CTD |
| G |
Pkp2 |
plakophilin 2 |
|
increases expression |
EXP |
11 |
86,553,493 |
86,584,425 |
RGD:6480464 |
CTD |
| G |
Pkp3 |
plakophilin 3 |
|
affects response to substance |
ISO |
1 |
201,276,790 |
201,287,799 |
RGD:6480464 |
CTD |
| G |
Plekhg5 |
pleckstrin homology domain containing, family G (with RhoGef domain) member 5 |
|
affects response to substance |
ISO |
5 |
169,301,095 |
169,344,134 |
RGD:6480464 |
CTD |
| G |
Pnpla2 |
patatin-like phospholipase domain containing 2 |
|
increases expression |
EXP |
1 |
201,641,939 |
201,647,021 |
RGD:6480464 |
CTD |
| G |
Polg2 |
polymerase (DNA directed), gamma 2, accessory subunit |
|
affects response to substance |
ISO |
10 |
96,120,205 |
96,130,221 |
RGD:6480464 |
CTD |
| G |
Polh |
polymerase (DNA directed), eta |
|
multiple interactions |
ISO |
9 |
10,341,975 |
10,375,983 |
RGD:6480464 |
CTD |
| G |
Polr2e |
polymerase (RNA) II (DNA directed) polypeptide E |
|
decreases expression |
ISO |
7 |
11,179,283 |
11,183,205 |
RGD:6480464 |
CTD |
| G |
Ppm1g |
protein phosphatase, Mg2+/Mn2+ dependent, 1G |
|
decreases expression |
ISO |
6 |
25,145,569 |
25,149,811 |
RGD:6480464 |
CTD |
| G |
Prc1 |
protein regulator of cytokinesis 1 |
|
decreases expression |
ISO |
1 |
136,112,674 |
136,133,720 |
RGD:6480464 |
CTD |
| G |
Prex1 |
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
|
affects response to substance |
ISO |
3 |
157,693,897 |
157,863,943 |
RGD:6480464 |
CTD |
| G |
Prkaa2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
|
affects response to substance |
ISO |
5 |
126,007,672 |
126,074,012 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
decreases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prm2 |
protamine 2 |
|
decreases expression |
ISO |
10 |
4,813,692 |
4,814,128 |
RGD:6480464 |
CTD |
| G |
Prph |
peripherin |
|
decreases expression |
EXP |
7 |
137,836,152 |
137,839,931 |
RGD:6480464 |
CTD |
| G |
Prrx2 |
paired related homeobox 2 |
|
affects response to substance |
ISO |
3 |
9,899,066 |
9,936,837 |
RGD:6480464 |
CTD |
| G |
Prss12 |
protease, serine, 12 neurotrypsin (motopsin) |
|
affects response to substance |
ISO |
2 |
220,194,590 |
220,254,502 |
RGD:6480464 |
CTD |
| G |
Pth2r |
parathyroid hormone 2 receptor |
|
decreases expression |
EXP |
9 |
63,942,380 |
64,049,405 |
RGD:6480464 |
CTD |
| G |
Ptpn3 |
protein tyrosine phosphatase, non-receptor type 3 |
|
decreases expression |
ISO |
5 |
75,106,880 |
75,222,735 |
RGD:6480464 |
CTD |
| G |
Pzp |
pregnancy-zone protein |
|
decreases expression |
ISO |
4 |
165,505,104 |
165,579,027 |
RGD:6480464 |
CTD |
| G |
Qpct |
glutaminyl-peptide cyclotransferase |
|
affects response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Rab27b |
RAB27B, member RAS oncogene family |
|
affects response to substance |
ISO |
18 |
66,682,627 |
66,747,813 |
RGD:6480464 |
CTD |
| G |
Rad23a |
RAD23 homolog A (S. cerevisiae) |
|
decreases expression |
ISO |
19 |
24,971,070 |
24,976,901 |
RGD:6480464 |
CTD |
| G |
Rad51 |
RAD51 homolog (S. cerevisiae) |
|
decreases expression |
ISO |
3 |
105,625,265 |
105,650,392 |
RGD:6480464 |
CTD |
| G |
Rad9a |
RAD9 homolog A (S. pombe) |
|
decreases expression |
ISO |
1 |
206,778,534 |
206,785,230 |
RGD:6480464 |
CTD |
| G |
Rbm19 |
RNA binding motif protein 19 |
|
affects response to substance |
ISO |
12 |
37,619,153 |
37,704,471 |
RGD:6480464 |
CTD |
| G |
Rcn1 |
reticulocalbin 1, EF-hand calcium binding domain |
|
decreases expression |
ISO |
3 |
90,832,151 |
90,846,395 |
RGD:6480464 |
CTD |
| G |
Rel |
v-rel reticuloendotheliosis viral oncogene homolog (avian) |
|
multiple interactions |
EXP |
14 |
104,645,370 |
104,671,275 |
RGD:6480464 |
CTD |
| G |
Rel |
v-rel reticuloendotheliosis viral oncogene homolog (avian) |
|
multiple interactions |
EXP |
14 |
104,645,370 |
104,671,275 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Relb |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Relb |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rfc3 |
replication factor C (activator 1) 3 |
|
decreases expression |
EXP |
12 |
3,224,493 |
3,235,256 |
RGD:6480464 |
CTD |
| G |
Rgcc |
regulator of cell cycle |
|
affects response to substance |
ISO |
15 |
60,451,831 |
60,452,229 |
RGD:6480464 |
CTD |
| G |
Rgp1 |
RGP1 retrograde golgi transport homolog (S. cerevisiae) |
|
affects response to substance |
ISO |
5 |
60,057,647 |
60,061,853 |
RGD:6480464 |
CTD |
| G |
Rgr |
retinal G protein coupled receptor |
|
decreases expression |
ISO |
16 |
13,242,336 |
13,256,964 |
RGD:6480464 |
CTD |
| G |
Rhobtb3 |
Rho-related BTB domain containing 3 |
|
affects response to substance |
ISO |
2 |
2,911,820 |
2,967,473 |
RGD:6480464 |
CTD |
| G |
Rit2 |
Ras-like without CAAX 2 |
|
decreases expression |
ISO |
18 |
23,316,074 |
23,682,927 |
RGD:6480464 |
CTD |
| G |
Rnase4 |
ribonuclease, RNase A family 4 |
|
increases expression |
ISO |
15 |
27,073,756 |
27,090,441 |
RGD:6480464 |
CTD |
| G |
Rorb |
RAR-related orphan receptor B |
|
affects expression |
EXP |
1 |
222,545,682 |
222,726,307 |
RGD:6480464 |
CTD |
| G |
Scamp5 |
secretory carrier membrane protein 5 |
|
affects response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Scn1b |
sodium channel, voltage-gated, type I, beta |
|
increases expression |
EXP |
1 |
86,162,254 |
86,172,128 |
RGD:6480464 |
CTD |
| G |
Scn8a |
sodium channel, voltage gated, type VIII, alpha subunit |
|
affects response to substance |
ISO |
7 |
139,686,180 |
139,794,282 |
RGD:6480464 |
CTD |
| G |
Sdc1 |
syndecan 1 |
|
affects response to substance |
ISO |
6 |
32,253,352 |
32,275,812 |
RGD:6480464 |
CTD |
| G |
Sema3a |
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A |
|
affects response to substance |
ISO |
4 |
17,575,112 |
17,790,100 |
RGD:6480464 |
CTD |
| G |
Sept4 |
septin 4 |
|
decreases expression |
EXP |
10 |
75,871,422 |
75,880,878 |
RGD:6480464 |
CTD |
| G |
Sept5 |
septin 5 |
|
decreases expression |
ISO |
11 |
84,365,193 |
84,370,972 |
RGD:6480464 |
CTD |
| G |
Serpinb1a |
serine (or cysteine) proteinase inhibitor, clade B, member 1a |
|
affects response to substance |
ISO |
17 |
37,950,875 |
37,959,284 |
RGD:6480464 |
CTD |
| G |
Sf1 |
splicing factor 1 |
|
affects response to substance |
ISO |
1 |
209,146,177 |
209,159,459 |
RGD:6480464 |
CTD |
| G |
Sfpq |
splicing factor proline/glutamine-rich |
|
decreases expression |
ISO |
5 |
146,460,306 |
146,469,289 |
RGD:6480464 |
CTD |
| G |
Sgca |
sarcoglycan, alpha (dystrophin-associated glycoprotein) |
|
decreases expression |
ISO |
10 |
83,647,336 |
83,660,800 |
RGD:6480464 |
CTD |
| G |
Shmt2 |
serine hydroxymethyltransferase 2 (mitochondrial) |
|
decreases expression |
ISO |
7 |
67,494,470 |
67,499,540 |
RGD:6480464 |
CTD |
| G |
Slc10a1 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
|
increases expression |
ISO |
6 |
104,735,839 |
104,749,464 |
RGD:6480464 |
CTD |
| G |
Slc12a1 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 1 |
|
decreases expression |
EXP |
3 |
112,455,897 |
112,534,752 |
RGD:6480464 |
CTD |
| G |
Slc12a2 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 2 |
|
increases expression |
EXP |
18 |
53,673,215 |
53,741,352 |
RGD:6480464 |
CTD |
| G |
Slc14a1 |
solute carrier family 14 (urea transporter), member 1 |
|
affects response to substance |
ISO |
18 |
75,024,200 |
75,048,481 |
RGD:6480464 |
CTD |
| G |
Slc15a2 |
solute carrier family 15 (H+/peptide transporter), member 2 |
|
affects response to substance |
ISO |
11 |
65,819,551 |
65,849,924 |
RGD:6480464 |
CTD |
| G |
Slc16a2 |
solute carrier family 16, member 2 (thyroid hormone transporter) |
|
increases expression |
ISO |
X |
91,700,554 |
91,825,108 |
RGD:6480464 |
CTD |
| G |
Slc19a2 |
solute carrier family 19 (thiamine transporter), member 2 |
|
decreases expression |
EXP |
13 |
80,017,780 |
80,031,777 |
RGD:6480464 |
CTD |
| G |
Slc22a5 |
solute carrier family 22 (organic cation/carnitine transporter), member 5 |
|
affects response to substance |
ISO |
10 |
39,311,729 |
39,338,718 |
RGD:6480464 |
CTD |
| G |
Slc30a3 |
solute carrier family 30 (zinc transporter), member 3 |
|
decreases expression |
ISO |
6 |
25,257,765 |
25,264,794 |
RGD:6480464 |
CTD |
| G |
Slc3a2 |
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
|
increases expression |
EXP |
1 |
211,375,889 |
211,390,313 |
RGD:6480464 |
CTD |
| G |
Slc6a2 |
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
|
increases expression |
ISO |
19 |
15,098,281 |
15,139,898 |
RGD:6480464 |
CTD |
| G |
Slco1a2 |
solute carrier organic anion transporter family, member 1A2 |
|
decreases expression |
ISO |
4 |
179,790,209 |
179,851,288 |
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Smarcd1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 |
|
increases expression |
ISO |
7 |
138,444,520 |
138,455,060 |
RGD:6480464 |
CTD |
| G |
Smpd2 |
sphingomyelin phosphodiesterase 2, neutral membrane |
|
increases expression |
ISO |
20 |
45,448,774 |
45,451,887 |
RGD:6480464 |
CTD |
| G |
Snapc1 |
small nuclear RNA activating complex, polypeptide 1 |
|
increases expression |
ISO |
6 |
96,479,145 |
96,505,377 |
RGD:6480464 |
CTD |
| G |
Snapc3 |
small nuclear RNA activating complex, polypeptide 3 |
|
increases expression |
ISO |
5 |
102,275,379 |
102,302,085 |
RGD:6480464 |
CTD |
| G |
Sncg |
synuclein, gamma (breast cancer-specific protein 1) |
|
increases expression |
ISO |
16 |
10,025,978 |
10,030,516 |
RGD:6480464 |
CTD |
| G |
Snrpb2 |
small nuclear ribonucleoprotein polypeptide B'' |
|
increases expression |
ISO |
3 |
131,416,677 |
131,426,007 |
RGD:6480464 |
CTD |
| G |
Socs1 |
suppressor of cytokine signaling 1 |
|
decreases expression |
ISO |
10 |
4,819,971 |
4,820,609 |
RGD:6480464 |
CTD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
decreases activity |
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
affects response to substance |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sod2 |
superoxide dismutase 2, mitochondrial |
|
decreases activity |
ISO |
1 |
41,862,997 |
41,870,327 |
RGD:6480464 |
CTD |
| G |
Sorbs2 |
sorbin and SH3 domain containing 2 |
|
decreases expression |
ISO |
16 |
49,722,539 |
49,917,550 |
RGD:6480464 |
CTD |
| G |
Sox9 |
SRY (sex determining region Y)-box 9 |
|
affects response to substance |
ISO |
10 |
102,392,187 |
102,394,256 |
RGD:6480464 |
CTD |
| G |
Sparc |
secreted protein, acidic, cysteine-rich (osteonectin) |
|
affects response to substance |
ISO |
10 |
40,809,730 |
40,831,481 |
RGD:6480464 |
CTD |
| G |
Speg |
SPEG complex locus |
|
decreases expression |
ISO |
9 |
74,652,526 |
74,709,904 |
RGD:6480464 |
CTD |
| G |
Spen |
spen homolog, transcriptional regulator (Drosophila) |
|
affects response to substance |
ISO |
5 |
160,359,738 |
160,414,311 |
RGD:6480464 |
CTD |
| G |
Sqle |
squalene epoxidase |
|
affects response to substance |
ISO |
7 |
96,096,897 |
96,111,772 |
RGD:6480464 |
CTD |
| G |
Srp14 |
signal recognition particle 14 |
|
decreases expression |
ISO |
3 |
104,906,842 |
104,910,533 |
RGD:6480464 |
CTD |
| G |
Sry |
sex determining region Y |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
|
affects response to substance |
ISO |
7 |
104,467,678 |
104,474,345 |
RGD:6480464 |
CTD |
| G |
St8sia1 |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 |
|
increases expression |
ISO |
4 |
180,722,382 |
180,852,639 |
RGD:6480464 |
CTD |
| G |
Stam |
signal transducing adaptor molecule (SH3 domain and ITAM motif) 1 |
|
decreases expression |
ISO |
17 |
88,276,082 |
88,321,955 |
RGD:6480464 |
CTD |
| G |
Stc1 |
stanniocalcin 1 |
|
affects response to substance |
ISO |
15 |
49,566,885 |
49,577,539 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
affects response to substance |
ISO |
5 |
153,226,420 |
153,232,084 |
RGD:6480464 |
CTD |
| G |
Sts |
steroid sulfatase (microsomal), isozyme S |
|
increases expression |
ISO |
X |
63,915,803 |
63,923,834 |
RGD:6480464 |
CTD |
| G |
Stx1b |
syntaxin 1B |
|
decreases expression |
ISO |
1 |
187,092,014 |
187,108,481 |
RGD:6480464 |
CTD |
| G |
Stxbp2 |
syntaxin binding protein 2 |
|
decreases expression |
ISO |
12 |
2,511,793 |
2,522,818 |
RGD:6480464 |
CTD |
| G |
Stxbp6 |
syntaxin binding protein 6 (amisyn) |
|
affects response to substance |
ISO |
6 |
64,249,917 |
64,490,471 |
RGD:6480464 |
CTD |
| G |
Synpo2 |
synaptopodin 2 |
|
affects response to substance |
ISO |
2 |
219,778,072 |
219,937,734 |
RGD:6480464 |
CTD |
| G |
Syp |
synaptophysin |
|
multiple interactions |
EXP |
X |
26,890,307 |
26,905,319 |
RGD:6480464 |
CTD |
| G |
Syp |
synaptophysin |
|
decreases expression |
EXP |
X |
26,890,307 |
26,905,319 |
RGD:6480464 |
CTD |
| G |
Tac1 |
tachykinin, precursor 1 |
|
decreases expression |
ISO |
4 |
32,649,666 |
32,657,632 |
RGD:6480464 |
CTD |
| G |
Tagln |
transgelin |
|
affects response to substance |
ISO |
8 |
48,902,208 |
48,907,682 |
RGD:6480464 |
CTD |
| G |
Tbx3 |
T-box 3 |
|
affects response to substance |
ISO |
12 |
38,155,494 |
38,166,670 |
RGD:6480464 |
CTD |
| G |
Tcf21 |
transcription factor 21 |
|
decreases expression |
ISO |
1 |
23,211,054 |
23,213,913 |
RGD:6480464 |
CTD |
| G |
Tert |
telomerase reverse transcriptase |
|
decreases response to substance |
ISO |
1 |
30,445,180 |
30,465,942 |
RGD:6480464 |
CTD |
| G |
Tfap2c |
transcription factor AP-2 gamma |
|
affects response to substance |
ISO |
3 |
163,459,283 |
163,467,166 |
RGD:6480464 |
CTD |
| G |
Tfpi2 |
tissue factor pathway inhibitor 2 |
|
affects response to substance |
ISO |
4 |
28,807,080 |
28,811,502 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
increases activity |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Th |
tyrosine hydroxylase |
|
increases expression |
EXP |
1 |
203,164,253 |
203,171,506 |
RGD:6480464 |
CTD |
| G |
Thbd |
thrombomodulin |
|
affects response to substance |
ISO |
3 |
137,158,955 |
137,162,607 |
RGD:6480464 |
CTD |
| G |
Tle3 |
transducin-like enhancer of split 3 (E(sp1) homolog, Drosophila) |
|
decreases expression |
ISO |
8 |
65,485,758 |
65,531,052 |
RGD:6480464 |
CTD |
| G |
Tmem158 |
transmembrane protein 158 |
|
affects response to substance |
ISO |
8 |
128,037,014 |
128,038,012 |
RGD:6480464 |
CTD |
| G |
Tmem19 |
transmembrane protein 19 |
|
affects response to substance |
ISO |
7 |
54,606,463 |
54,632,803 |
RGD:6480464 |
CTD |
| G |
Tmprss15 |
transmembrane protease, serine 15 |
|
affects response to substance |
ISO |
11 |
18,017,213 |
18,167,545 |
RGD:6480464 |
CTD |
| G |
Tnc |
tenascin C |
|
affects response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
EXP |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf11b |
tumor necrosis factor receptor superfamily, member 11b |
|
decreases expression |
ISO |
7 |
90,606,424 |
90,634,431 |
RGD:6480464 |
CTD |
| G |
Tnfrsf19 |
tumor necrosis factor receptor superfamily, member 19 |
|
affects response to substance |
ISO |
15 |
40,051,695 |
40,117,968 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
affects response to substance |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
affects response to substance |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases response to substance |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases response to substance |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tpd52l1 |
tumor protein D52-like 1 |
|
affects response to substance |
ISO |
1 |
26,788,964 |
26,951,930 |
RGD:6480464 |
CTD |
| G |
Trim50 |
tripartite motif-containing 50 |
|
affects response to substance |
ISO |
12 |
22,455,550 |
22,470,523 |
RGD:6480464 |
CTD |
| G |
Tspan4 |
tetraspanin 4 |
|
decreases expression |
ISO |
1 |
201,661,391 |
201,681,042 |
RGD:6480464 |
CTD |
| G |
Tubb5 |
tubulin, beta 5 class I |
|
increases expression |
ISO |
20 |
3,060,224 |
3,090,776 |
RGD:6480464 |
CTD |
| G |
Tubg1 |
tubulin, gamma 1 |
|
decreases expression |
ISO |
10 |
90,137,813 |
90,144,403 |
RGD:6480464 |
CTD |
| G |
Tufm |
Tu translation elongation factor, mitochondrial |
|
affects response to substance |
ISO |
1 |
185,631,333 |
185,634,940 |
RGD:6480464 |
CTD |
| G |
Tulp3 |
tubby-like protein 3 |
|
affects response to substance |
ISO |
4 |
165,334,192 |
165,376,105 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
multiple interactions |
EXP |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Txnrd1 |
thioredoxin reductase 1 |
|
decreases activity |
EXP |
7 |
23,055,544 |
23,093,815 |
RGD:6480464 |
CTD |
| G |
Ugt8 |
UDP glycosyltransferase 8 |
|
increases expression |
ISO |
2 |
222,977,966 |
223,048,277 |
RGD:6480464 |
CTD |
| G |
Vamp4 |
vesicle-associated membrane protein 4 |
|
affects response to substance |
ISO |
13 |
78,247,189 |
78,269,770 |
RGD:6480464 |
CTD |
| G |
Vgf |
VGF nerve growth factor inducible |
|
decreases expression |
ISO |
12 |
20,903,304 |
20,906,327 |
RGD:6480464 |
CTD |
| G |
Vldlr |
very low density lipoprotein receptor |
|
affects response to substance |
ISO |
1 |
230,666,736 |
230,697,748 |
RGD:6480464 |
CTD |
| G |
Wasf2 |
WAS protein family, member 2 |
|
affects response to substance |
ISO |
5 |
151,930,683 |
151,948,752 |
RGD:6480464 |
CTD |
| G |
Wfdc1 |
WAP four-disulfide core domain 1 |
|
affects response to substance |
ISO |
19 |
49,924,440 |
49,943,113 |
RGD:6480464 |
CTD |
| G |
Wipf1 |
WAS/WASL interacting protein family, member 1 |
|
decreases expression |
ISO |
3 |
55,944,490 |
56,003,310 |
RGD:6480464 |
CTD |
| G |
Wisp1 |
WNT1 inducible signaling pathway protein 1 |
|
affects response to substance |
ISO |
7 |
104,263,089 |
104,291,621 |
RGD:6480464 |
CTD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
affects response to substance |
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:6480464 |
CTD |
| G |
Wt1 |
Wilms tumor 1 |
|
decreases response to substance |
ISO |
3 |
90,529,704 |
90,577,280 |
RGD:6480464 |
CTD |
| G |
Ywhah |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide |
|
decreases expression |
ISO |
14 |
83,448,395 |
83,457,778 |
RGD:6480464 |
CTD |
| G |
Zbtb17 |
zinc finger and BTB domain containing 17 |
|
decreases expression |
ISO |
5 |
160,337,988 |
160,359,060 |
RGD:6480464 |
CTD |
| G |
Zc3h13 |
zinc finger CCCH type containing 13 |
|
affects response to substance |
ISO |
15 |
56,155,138 |
56,219,559 |
RGD:6480464 |
CTD |
| G |
Zfp112 |
zinc finger protein 112 |
|
affects response to substance |
ISO |
1 |
79,330,407 |
79,345,279 |
RGD:6480464 |
CTD |
| G |
Zfp189 |
zinc finger protein 189 |
|
increases expression |
EXP |
5 |
66,266,848 |
66,278,203 |
RGD:6480464 |
CTD |
| G |
Zfp655 |
zinc finger protein 655 |
|
affects response to substance |
ISO |
12 |
9,670,178 |
9,687,864 |
RGD:6480464 |
CTD |
| G |
Zyx |
zyxin |
|
decreases expression |
ISO |
4 |
70,119,162 |
70,128,016 |
RGD:6480464 |
CTD |
Term paths to the root
|